APA (7th ed.) Citation

MP, J., L, S., AM, S., C, V. C., D, R., M, L., . . . S, V. L. (2015). Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease. Molecular oncology, 9(6), 1218. https://doi.org/10.1016/j.molonc.2015.02.006

Chicago Style (17th ed.) Citation

MP, Jansen, et al. "Decreased Expression of ABAT and STC2 Hallmarks ER-positive Inflammatory Breast Cancer and Endocrine Therapy Resistance in Advanced Disease." Molecular Oncology 9, no. 6 (2015): 1218. https://doi.org/10.1016/j.molonc.2015.02.006.

MLA (9th ed.) Citation

MP, Jansen, et al. "Decreased Expression of ABAT and STC2 Hallmarks ER-positive Inflammatory Breast Cancer and Endocrine Therapy Resistance in Advanced Disease." Molecular Oncology, vol. 9, no. 6, 2015, p. 1218, https://doi.org/10.1016/j.molonc.2015.02.006.